J Korean Soc Clin Neurophysiol.  2012 Dec;14(2):59-63.

Deep Brain Stimulation for Controlling Refractory Epilepsy: a Clinical Perspective

Affiliations
  • 1Department of Neurology, The Catholic University of Korea College of Medicine, Seoul, Korea. sonogung@catholic.ac.kr

Abstract

Epilepsy has continued to provide challenges to epileptologists, as a significant proportion of patients continue to suffer from seizures despite medical and surgical treatments. Deep brain stimulation (DBS) has emerged as a new therapeutic modality that has the potential to improve quality of life and occasionally be curative for patients with medically refractory epilepsy who are not surgical candidates. Several groups have used DBS in drug-resistant epilepsy cases for which resective surgery cannot be applied. The promising subcortical brain structures are anterior and centromedian nucleus of the thalamus, subthalamic nucleus, and other nuclei to treat epilepsy in light of previous clinical and experimental data. Recently two randomized trials of neurostimulation for controlling refractory epilepsy employed the strategies to stimulate electrodes placed on both anterior thalamic nuclei or near seizure foci in response to electroencephalographically detected epileptiform activity. However, the more large-scale, long-term clinical trials which elucidates optimal stimulation parameters, ideal selection criteria for epilepsy DBS should be performed before long. In order to continue to advance the frontier of this field, it is imperative to have a good grasp of the current body of knowledge.

Keyword

Deep brain stimulation; Intractable epilepsy; Anterior thalamic nucleus

MeSH Terms

Anterior Thalamic Nuclei
Brain
Deep Brain Stimulation
Electrodes
Epilepsy
Hand Strength
Humans
Intralaminar Thalamic Nuclei
Light
Patient Selection
Quality of Life
Seizures
Subthalamic Nucleus
Thalamus
Full Text Links
  • JKSCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr